Inhibitors | Comment | Organism | Structure |
---|---|---|---|
1-[(5S)-4-oxo-6-phenyl-5-[(phenylcarbonyl)amino]hexanoyl]-L-proline | - |
Homo sapiens | |
1-[(5S)-5-[(tert-butoxycarbonyl)amino]-4-oxo-6-phenylhexanoyl]-L-proline | - |
Homo sapiens | |
lisinopril | - |
Homo sapiens | |
N-[(5S)-4-oxo-6-phenyl-5-[(phenylcarbonyl)amino]hexanoyl]-L-phenylalanine | - |
Homo sapiens | |
N-[(5S)-4-oxo-6-phenyl-5-[(phenylcarbonyl)amino]hexanoyl]-L-tryptophan | - |
Homo sapiens | |
N-[(5S)-5-[(tert-butoxycarbonyl)amino]-4-oxo-6-phenylhexanoyl]-L-phenylalanine | - |
Homo sapiens | |
N-[(5S)-5-[(tert-butoxycarbonyl)amino]-4-oxo-6-phenylhexanoyl]-L-tryptophan | - |
Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P12821 | recombinant ACE construct tACEDELTA36NJ | - |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
testis | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
benzyloxycarbonyl-Phe-His-Leu + H2O | - |
Homo sapiens | benzyloxycarbonyl-Phe + His-Leu | - |
? |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.000051 | - |
lisinopril | inhibition of C-domain | Homo sapiens | |
0.0001315 | - |
lisinopril | inhibition of N-domain | Homo sapiens | |
0.0008 | - |
N-[(5S)-4-oxo-6-phenyl-5-[(phenylcarbonyl)amino]hexanoyl]-L-tryptophan | inhibition of C-domain | Homo sapiens | |
0.0018 | - |
1-[(5S)-4-oxo-6-phenyl-5-[(phenylcarbonyl)amino]hexanoyl]-L-proline | inhibition of C-domain | Homo sapiens | |
0.0133 | - |
N-[(5S)-5-[(tert-butoxycarbonyl)amino]-4-oxo-6-phenylhexanoyl]-L-tryptophan | inhibition of N-domain | Homo sapiens | |
0.0237 | - |
N-[(5S)-4-oxo-6-phenyl-5-[(phenylcarbonyl)amino]hexanoyl]-L-phenylalanine | inhibition of C-domain | Homo sapiens | |
0.0336 | - |
1-[(5S)-5-[(tert-butoxycarbonyl)amino]-4-oxo-6-phenylhexanoyl]-L-proline | inhibition of N-domain | Homo sapiens | |
0.043 | - |
N-[(5S)-5-[(tert-butoxycarbonyl)amino]-4-oxo-6-phenylhexanoyl]-L-phenylalanine | inhibition of N-domain | Homo sapiens | |
0.0452 | - |
1-[(5S)-4-oxo-6-phenyl-5-[(phenylcarbonyl)amino]hexanoyl]-L-proline | inhibition of N-domain | Homo sapiens | |
0.0843 | - |
N-[(5S)-4-oxo-6-phenyl-5-[(phenylcarbonyl)amino]hexanoyl]-L-phenylalanine | inhibition of N-domain | Homo sapiens | |
0.1435 | - |
1-[(5S)-5-[(tert-butoxycarbonyl)amino]-4-oxo-6-phenylhexanoyl]-L-proline | inhibition of C-domain | Homo sapiens | |
0.1957 | - |
N-[(5S)-4-oxo-6-phenyl-5-[(phenylcarbonyl)amino]hexanoyl]-L-tryptophan | inhibition of N-domain | Homo sapiens | |
0.3129 | - |
N-[(5S)-5-[(tert-butoxycarbonyl)amino]-4-oxo-6-phenylhexanoyl]-L-phenylalanine | inhibition of C-domain | Homo sapiens | |
0.3813 | - |
N-[(5S)-5-[(tert-butoxycarbonyl)amino]-4-oxo-6-phenylhexanoyl]-L-tryptophan | inhibition of C-domain | Homo sapiens |